Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New dressing could speed healing of chronic wounds

NCT ID NCT07261501

Disease control Sponsor: Peking University Third Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new antibacterial absorbable dressing on 30 adults with chronic non-healing wounds. The dressing is designed to break down in the body and help wounds heal faster. Researchers will measure how much the wound shrinks after 3 weeks and how many wounds fully close. The goal is to see if this dressing is safe and effective for people whose wounds have not improved for at least a week.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
antibacterial absorbable wound dressing (device)
What this could lead to
If it works, this dressing could help heal stubborn chronic wounds faster and more effectively than current options.
What could go wrong
This is a small early-stage trial with only 30 participants, so results may not apply to everyone. The dressing might not work better than standard care, and there is a risk of infection or allergic reaction.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 30 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 months to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age : 18-80 years * Wound Type : Chronic non-healing ulcers\* with no signs of healing progression for ≥1 week * Wound Area : 1-35 cm² * Infection Status : Local infection, contamination, or colonization\*\* as classified by IWII Wound Infection Staging * Wound Phase : Late necrotic stabilization phase, granulation phase, or epithelial migration phase\*\*\* * Consent : Voluntary participation with signed informed consent Exclusion Criteria: * Severe Comorbidities : Acute myocardial infarction, heart failure, hepatitis, shock, respiratory failure, or other critical conditions requiring stabilization * Uncontrolled Diabetes : Fasting blood glucose \>15 mmol/L or HbA1c \>12% * Active Wound Hemorrhage : Bleeding precluding standard wound therapy * Critical Laboratory Values : Serum albumin \<20 g/L Hemoglobin \<60 g/L Platelet count \<50×10⁹/L * Systemic Infection : Disseminated/systemic infection requiring antibiotic therapy * Malignancy : Advanced cancer patients，Current radiotherapy/chemotherapy，Malignant (cancer-related) ulcers * Untreated Burns : Full-thickness (third-degree) burns without escharotomy * Active Autoimmune Disease : Flare-up phase of autoimmune disorders * Pregnancy/Lactation : Pregnant or breastfeeding women * Allergy : Hypersensitivity to absorbable wound repair materials or polyhexamethylene biguanide hydrochloride * Non-compliance : Inability to cooperate or psychiatric disorders * Investigator's Discretion : Any condition deemed to compromise wound healing or study adherence

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic non-healing wounds are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

chronic ulcer of skin

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Wound heal Wound healing delayed

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Peking University Third Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100191, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.